Cofoe Medical Technology Co.,Ltd. (SHE:301087)
China · Delayed Price · Currency is CNY 37.50
-0.34 (-0.90%)
At close: Aug 8, 2025, 2:57 PM CST
Ligand Pharmaceuticals Market Cap
Cofoe Medical Technology has a market cap or net worth of 7.63 billion as of August 8, 2025. Its market cap has increased by 12.65% in one year.
Market Cap
7.63B
Enterprise Value
5.88B
Revenue
2.91B
Ranking
n/a
PE Ratio
25.54
Stock Price
$37.50
Market Cap Chart
Since October 25, 2021, Cofoe Medical Technology's market cap has decreased from 14.24B to 7.63B, a decrease of -46.42%. That is a compound annual growth rate of -15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 7.63B | 6.05% |
| Dec 31, 2024 | 7.19B | -7.68% |
| Dec 29, 2023 | 7.79B | 2.43% |
| Dec 30, 2022 | 7.61B | -39.76% |
| Dec 31, 2021 | 12.63B | -11.31% |
| Oct 25, 2021 | 14.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 406.93B |
| Shenzhen Mindray Bio-Medical Electronics | 279.02B |
| WuXi AppTec | 264.87B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.83B |
| Aier Eye Hospital Group | 118.61B |
| Sichuan Biokin Pharmaceutical | 118.48B |
| Shanghai United Imaging Healthcare | 107.18B |
| Yunnan Baiyao Group Co.,Ltd | 99.72B |